Tarik Asselah

32PUBLICATIONS
102CO-AUTHORS
Haematological tumoursMedical biotechnology diagnostics (incl. biosensors)Gene and molecular therapyMedical molecular engineering of nucleic acids and proteinsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Sep 18, 2026
High rates of transition to immune active disease in a cohort of strictly defined immune tolerant patients with chronic hepatitis B: results from the RADICAL consortium.

|Aug 19, 2026
Hepatology: Emerging Paradigms in MASLD, Viral Hepatitis, Cholestatic Liver Disease, Portal Hypertension and Hepatocellular Carcinoma: Summary of the First Annual Paris International Liver Meeting 2026.

|Aug 17, 2026
Risk of Liver Cancer From Major Causes Compared to Smoking and Lung Cancer: A Systematic Review and Meta-Analysis.

|May 28, 2026
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection.

|Nov 10, 2025
A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D.

Tarik Asselah, Michael A Chattergoon, Alina Jucov

|Nov 05, 2025
Peginterferon alpha-2a add-on to siRNA JNJ-73763989 in untreated patients with HBeAg-positive chronic hepatitis B virus (HBV) infection: the phase 2 REEF-IT study.

Patrick T F Kennedy, Scott Fung, Maria Buti

Pageof 6

Frequent Collaborators

3 joint publications

Pietro Lampertico

3 joint publications

Patrick Marcellin

2 joint publications

Zobair M Younossi

2 joint publications

Maurizia R Brunetto